Psychopharmakotherapie
Readership
Clinical Pharmacologists, Mental Health Evaluators, Neurologists, Pharmacologists, Psychiatric Nurses, Psychiatrists, Psychologists, Psychotherapists, Toxicologists
Scope
Psychopharmakotherapie (PPT) is the only German-language journal with a single focus on the pharmacotherapy of psychiatric and neurologic diseases, especially under the aspects pharmacology, evaluation in clinical studies, postmarketing surveillance, drug risks, pharmacoeconomics, and practical experiences . Its aim is to inform German-speaking psychiatrists and neurologists (clinicians as well as practitioners) on best practice and current developments in this field. PPT provides reviews, original (= research) papers, editorials, commentaries, case reports, and short reports on high-level publications and congress presentations. Reviews, original papers, commentaries, and case reports are subject to peer review.
Sponsoring Association(s)
German Society for Experimental and Clinical Pharmacology and Toxicology (Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie) (DGPT), Institute for Drug Safety in Psychiatry (Institut für Arzneimittelsicherheit in der Psychiatrie) (AMSP)
Publisher Name
Wissenschaftliche Verlagsgesellschaft
Frequency
Journal Contact
Author Submission Guidelines